Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1512681

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1512681

Global Postnatal Probiotic Supplements Market - 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Overview

Global Postnatal Probiotic Supplements Market reached US$ 19.1 million in 2023 and is expected to reach US$ 32.9 million by 2031, growing with a CAGR of 8.1% during the forecast period 2024-2031.

The postnatal probiotic supplements market has emerged as a significant segment within the broader dietary supplement industry, catering specifically to the health needs of new mothers during the postpartum period. These supplements are designed to support maternal health, aid in recovery after childbirth, and enhance lactation for breastfeeding mothers. Key factors driving market growth include increasing awareness of probiotics' health benefits, rising consumer demand for natural health solutions, and endorsements from healthcare professionals.

Probiotic supplements for postnatal use typically contain strains such as Lactobacillus and Bifidobacterium, known for their ability to promote gut health, strengthen the immune system, and potentially alleviate common postpartum issues like digestive discomfort. Market expansion is also propelled by research highlighting probiotics' role in enhancing maternal and infant health outcomes, thereby encouraging their adoption among new mothers seeking safe and effective ways to support their well-being and that of their newborns.

The general well-being and lactation support probiotic segment in postnatal probiotic supplements market accounts over 31.14% share. Similarly, Asia-Pacific dominates the postnatal probiotic supplements market, capturing the largest market share of over 1/3rd. The demand for postnatal probiotic supplements in the Asia-Pacific region is witnessing robust growth driven by demographic shifts, cultural influences, and increasing health consciousness among consumers.

Dynamics

Rising Awareness of Postnatal Health and Wellness

The postnatal period, spanning the first 6 weeks (42 days) after childbirth, is crucial for maternal health. According to the World Health Organization (WHO), over 60% of global maternal deaths occur during this postpartum phase, with three-fourths of these deaths occurring within the first week after delivery. This statistic underscores the critical importance of postpartum care and highlights the need for effective health interventions during this vulnerable period.

Rising awareness of postnatal health and wellness has consequently driven demand for probiotic supplements, which are recognized for their potential to support digestive health, boost immunity, and aid in mood regulation. This growing awareness is bolstered by educational efforts from healthcare providers and health organizations, emphasizing the benefits of probiotics in promoting overall well-being post-childbirth.

As the market for postnatal probiotic supplements expands, supported by innovations in product formulation and regulatory standards ensuring safety and efficacy, it is poised for continued growth in meeting the specific health needs of new mothers worldwide. Companies are innovating to meet the specific needs of postnatal women with probiotic supplements. This includes formulating products with strains known to benefit gut health and immune function post-childbirth.

Growing Scientific Evidence Supporting Probiotic Benefits

Scientific research has increasingly demonstrated the benefits of probiotics in promoting health, particularly in the context of postnatal care. Studies highlight that probiotics can help restore and maintain a healthy balance of gut microbiota, which is crucial for digestive health and immune function. Moreover, probiotics have shown potential in mitigating common postpartum issues such as constipation, diarrhea, and vaginal infections. This growing body of evidence is instrumental in shaping consumer perceptions and driving demand for postnatal probiotic supplements.

Probiotics offer specific health benefits that are particularly relevant to postnatal women. These include supporting the restoration of gut health following the physiological stresses of childbirth, enhancing immune function during a critical recovery period, and potentially improving mood through the gut-brain axis. Such benefits are increasingly supported by clinical trials and studies, further validating the efficacy of probiotic supplementation in postpartum health management.

Regulatory Challenges and Compliance Issues

Regulatory challenges and compliance issues pose significant restraints to the postnatal probiotic supplements market, despite growing awareness of their potential health benefits. The regulatory landscape for dietary supplements, including probiotics, varies widely across different regions and countries, creating complexities for manufacturers in terms of product registration, labeling requirements, and health claims substantiation.

In many jurisdictions, including the United States and European Union, probiotic supplements are categorized as dietary supplements and thus subject to regulations ensuring consumer safety and product quality. Compliance with Good Manufacturing Practices (GMP) and rigorous testing protocols adds to production costs and operational complexities for manufacturers. Moreover, the need for clinical trials and substantiated health claims further lengthens the time to market for new probiotic formulations aimed at postnatal health.

Segment Analysis

The global postnatal probiotic supplements market is segmented based on product type, form, distribution channel, end-user and region.

The Surging Demand for Lactating Probiotics

Postnatal probiotic supplements are increasingly sought after for their potential to support overall maternal health and well-being. These supplements often contain probiotic strains that help maintain a healthy gut microbiota balance, which is crucial for digestive health and immune function. New mothers prioritize supplements that can boost their energy levels, support recovery after childbirth, and aid in managing postpartum symptoms such as fatigue and stress.

Probiotic supplements designed for lactation support are particularly valued for their ability to promote breast milk production and quality. Certain probiotic strains, such as Lactobacillus fermentum and Lactobacillus salivarius, have been studied for their potential to enhance lactation by influencing mammary gland health and milk composition. These supplements aim to address common lactation challenges faced by new mothers, including insufficient milk supply and related breastfeeding difficulties.

In July 2023, Danone S.A, a global nutrition food company has used its expertise in breastmilk research and breastfeeding to develop Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers, mastitis causes flu-like symptoms and breast pain, as well as skin rashes, fever, and breast engorgement. Breastmilk is widely recognized as nature's most powerful nutrition and tailormade for a baby's needs, providing many short- and long-term benefits for both babies and mothers.

Geographical Penetration

Demand for Postnatal Probiotic Supplements in Asia-Pacific

Asia-Pacific countries such as China, India, and Japan are experiencing rising birth rates and a growing emphasis on maternal and child health. This demographic trend is a significant driver for the demand for nutritional supplements, including probiotics, which are recognized for their potential to support maternal health during the postnatal period and enhance infant development.

Culturally, countries like China and India place strong emphasis on maternal well-being and the health of newborns. Probiotics are increasingly sought after due to their perceived benefits in promoting gut health, bolstering immune function, and aligning with traditional healthcare practices that prioritize natural remedies and preventive health measures.

Healthcare professionals and nutrition experts in the region are increasingly recommending probiotics to new mothers as part of comprehensive postnatal care regimens. These supplements are valued for their potential to improve digestive health, reduce the incidence of allergies in infants, and strengthen immunity during the critical early stages of life.

In May 2024, Probi strengthen its position in the Asia-Pacific region through strong customer collaborations. Probi held the first Probi CID in Shanghai to strengthen its relations and collaborations with customers. More than 30 customers participated, and presentations about the company's China strategic focus and capabilities were presented together with their product solutions, new clinical studies, and coming innovation pipeline.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the postnatal probiotic supplements market, both positively and negatively. On the positive side, heightened health awareness during the pandemic has led to increased consumer interest in health and wellness products, including probiotics.

Many consumers have turned to dietary supplements to boost their immune systems, support overall health, and manage stress, leading to a surge in demand for probiotic products. This trend has been particularly pronounced among new mothers seeking to enhance their postpartum health and well-being, driving growth in the postnatal probiotic supplements market.

On the negative side, the pandemic has caused significant disruptions to global supply chains, affecting the availability and cost of raw materials necessary for probiotic supplements. Lockdowns, travel restrictions, and labor shortages have hampered manufacturing and distribution processes, leading to delays and increased costs. Additionally, the economic downturn induced by the pandemic has affected consumer purchasing power, potentially limiting the market growth as some consumers may cut back on non-essential spending.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has had significant repercussions on the global supply chain, impacting the postnatal probiotic supplements market. Both countries are major producers and suppliers of various raw materials and ingredients used in dietary supplements, including probiotics. The conflict has led to disruptions in the production and export of these critical components, resulting in supply shortages and increased production costs for manufacturers worldwide.

The instability in the region has also caused fluctuations in energy prices, further driving up manufacturing and distribution costs. Consequently, companies in the postnatal probiotic supplements market have faced challenges in maintaining consistent supply and managing increased costs, which can affect product pricing and availability for consumers.

Moreover, the geopolitical tension has influenced market dynamics by creating uncertainty and affecting consumer confidence. Economic sanctions and trade restrictions imposed on Russia have complicated international trade and business operations, causing delays and uncertainties in market activities. This has particularly impacted European markets, where the dependence on Eastern European raw materials is substantial.

By Product Type

  • Single-Strain Probiotics
  • Multi-Strain Probiotics
  • Probiotic Blends
  • Prebiotics and Probiotics Combinations
  • Others

By Form

  • Tablets
  • Powder
  • Gummies
  • Others

By Application

  • Immune Health
  • Digestive Health
  • General Well-being and Lactation Support
  • Weight Management
  • Others

By Distribution Channel

  • Online
  • Offline

By End-User

  • Lactating Women
  • Postpartum Women

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Supplement company Ritual has expanded its pregnancy line with the launch of Natal Choline, which is formulated to support babies' cognitive function when taken during pregnancy. Over 95% of pregnant women, and 90% of women over the age of 19, aren't reaching recommended daily intakes of choline from diet alone, the company reports.
  • In July 2023, Danone has used its expertise in breastmilk research and breastfeeding and developed Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers1, mastitis (inflammation in the breast) causes flu-like symptoms and breast pain, as well as skin rashes, fever and breast engorgement.

Competitive Landscape

The major global players in the market include Danone S.A., Nestle S.A., Chr. Hansen Holding A/S, Probi AB, BioGaia AB, Jarrow Formulas, Inc., Church & Dwight Co., Inc., Renew Life, Archer Daniels Midland Company and i-Health, Inc.

Why Purchase the Report?

  • To visualize the global postnatal probiotic supplements market segmentation based on product type, form, application, end-user, distribution channel and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of postnatal probiotic supplements market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global postnatal probiotic supplements market report would provide approximately 78 tables, 75 figures, and 219 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB8524

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet By Product Type
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Awareness of Postnatal Health and Wellness
      • 4.1.1.2. Growing Scientific Evidence Supporting Probiotic Benefits
    • 4.1.2. Restraints
      • 4.1.2.1. Regulatory Challenges and Compliance Issues
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Single-Strain Probiotics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Multi-Strain Probiotics
  • 7.4. Probiotic Blends
  • 7.5. Prebiotics and Probiotics Combinations
  • 7.6. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Tablets*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Powder
  • 8.4. Gummies
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Immune Health*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Digestive Health
  • 9.4. General Well-being and Lactation Support
  • 9.5. Weight Management
  • 9.6. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Lactating Women*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Postpartum Women

11. By Distribution Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Online*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Offline

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Danone S.A. *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Nestle S.A.
  • 14.3. Chr. Hansen Holding A/S
  • 14.4. Probi AB
  • 14.5. BioGaia AB
  • 14.6. Jarrow Formulas, Inc.
  • 14.7. Church & Dwight Co., Inc.
  • 14.8. Renew Life
  • 14.9. Archer Daniels Midland Company
  • 14.10. i-Health, Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!